BLOC1S5
Biogenesis of lysosome-related organelles complex 1 subunit 5
Also known as: BL1S5_HUMAN, dJ303A1.3, MU, MUTED
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8TDH9
- Gene
- BLOC1S5
- Ensembl
- ENSG00000188428
- Chromosome
- 6
- Canonical length
- 187 aa
- Protein class
- Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Vesicles
OverviewNCBI Gene
This gene encodes a component of BLOC-1 (biogenesis of lysosome-related organelles complex 1). Components of this complex are involved in the biogenesis of organelles such as melanosomes and platelet-dense granules. A mouse model for Hermansky-Pudlak Syndrome is mutated in the murine version of this gene. Alternative splicing results in multiple transcript variants. Read-through transcription exists between this gene and the upstream EEF1E1 (eukaryotic translation elongation factor 1 epsilon 1) gene, as well as with the downstream TXNDC5 (thioredoxin domain containing 5) gene. [provided by RefSeq, Dec 2010]
Canonical amino-acid sequenceUniProt
187 residues, UniProt reviewed canonical sequence.
>Q8TDH9|BLOC1S5
1 MSGGGTETPV GCEAAPGGGS KKRDSLGTAG SAHLIIKDLG EIHSRLLDHR PVIQGETRYF
61 VKEFEEKRGL REMRVLENLK NMIHETNEHT LPKCRDTMRD SLSQVLQRLQ AANDSVCRLQ
121 QREQERKKIH SDHLVASEKQ HMLQWDNFMK EQPNKRAEVD EEHRKAMERL KEQYAEMEKD
181 LAKFSTFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against BLOC1S5 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.52
- Highest tissue expression
- 15 nTPM
Expression across tissuesHPA
Tissue
- kidney: 15 nTPM
- thymus: 15 nTPM
- liver: 11 nTPM
- tonsil: 10 nTPM
- breast: 9.8 nTPM
- ovary: 9.8 nTPM
Single-cell type
- microglia: 5.1 nCPM
- ependymal cells: 4.8 nCPM
- late spermatids: 4.7 nCPM
- oligodendrocytes: 3.8 nCPM
- oligodendrocyte progenitor cells: 3.6 nCPM
- astrocytes: 3.1 nCPM
Immune cell
- NK-cell: 20 nTPM
- memory B-cell: 19 nTPM
- eosinophil: 18 nTPM
- naive B-cell: 18 nTPM
- myeloid DC: 17 nTPM
- basophil: 16 nTPM
Brain region
- hypothalamus: 9.1 nTPM
- medulla oblongata: 8.4 nTPM
- white matter: 8.4 nTPM
- midbrain: 8.1 nTPM
- basal ganglia: 7.6 nTPM
- pons: 7.5 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about BLOC1S5.
Disease | AllUniProt
Conditions BLOC1S5 is implicated in, by any mechanism.
- Hermansky-Pudlak syndrome 11 (HPS11) MIM:619172
Disease | GeneticClinVar
6 pathogenic / likely-pathogenic of 54 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Hermansky-Pudlak syndrome 11
- Hermansky-Pudlak syndrome
- BLOC1S5-related disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.81
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.25
- DepMap mean gene effect
- 0.15
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 9% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- anterograde axonal transport
- anterograde synaptic vesicle transport
- endosome to melanosome transport
- melanosome organization
- melanosome transport
- neuron projection development
- otolith morphogenesis
- positive regulation of pigment cell differentiation
- vesicle-mediated transport
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Biogenesis of lysosome-related organelles complex 1 subunit 5
- Organelle biogenesis, Muted-like protein
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of BLOC1S5 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads BLOC1S5 as an antibody target. Whether an autoantibody or antibody against BLOC1S5 could matter depends on whether native BLOC1S5 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
BLOC1S5 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label BLOC1S5 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...